ABQURE
LIVE

Serial Number

90779841

Owner

UNIQURE IP B.V.

Attorney

Julianne Abelman

Filing Date

Jun 17, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ABQURE Trademark

Serial Number: 90779841 • Registration: 7102820

ABQURE is a trademark filed by UNIQURE IP B.V. on June 17, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

UNIQURE IP B.V. (20 trademarks)

MEIBERGDREEF 61
AMSTERDAM 1105BA , NL

Entity Type: 99

uniQure biopharma B.V. (17 trademarks)

Paasheuvelweg 25
Amsterdam 1105BP , NL

Entity Type: 26

Trademark Details

Filing Date

June 17, 2021

Registration Date

July 11, 2023

Published for Opposition

February 14, 2023

Goods & Services

Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing, namely, reagents for medical use; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases

Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics

Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 11, 2025 ASGN
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 4, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 4, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 4, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 4, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 4, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 11, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 11, 2023 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jun 8, 2023 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 1, 2023 AITU
NOTICE OF ALLOWANCE CANCELLED
Apr 14, 2023 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Apr 14, 2023 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 11, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 25, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 12, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 9, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 14, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 14, 2022 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 3, 2022 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 20, 2022 PBCR
ELECTRONIC RECORD REVIEW COMPLETE
Sep 7, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 2, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2022 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 10, 2022 RCCK
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 26, 2022 ERSI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 20, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 20, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 20, 2022 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 10, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 10, 2022 GNSL
SUSPENSION LETTER WRITTEN
Feb 10, 2022 CNSL
ASSIGNED TO EXAMINER
Feb 8, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2021 NWOS
NEW APPLICATION ENTERED
Jun 21, 2021 NWAP